353 related articles for article (PubMed ID: 16183515)
61. Combined use of nonculture-based lab techniques in the diagnosis and management of critically ill patients with invasive fungal infections.
Pemán J; Zaragoza R
Expert Rev Anti Infect Ther; 2012 Nov; 10(11):1321-30. PubMed ID: 23241189
[TBL] [Abstract][Full Text] [Related]
62. Diagnosis of filamentous fungi on tissue sections by immunohistochemistry using anti-aspergillus antibody.
Challa S; Uppin SG; Uppin MS; Pamidimukkala U; Vemu L
Med Mycol; 2015 Jun; 53(5):470-6. PubMed ID: 25980002
[TBL] [Abstract][Full Text] [Related]
63. Cerebral aspergillosis in the era of new antifungals: The CEREALS national cohort study Nationwide CEREbral Aspergillosis Lesional study (CEREALS).
Serris A; Benzakoun J; Danion F; Porcher R; Sonneville R; Wolff M; Kremer S; Letscher-Bru V; Fekkar A; Hekimian G; Pourcher V; Bougnoux ME; Poirée S; Ader F; Persat F; Cotton F; Tattevin P; Gangneux JP; Lelièvre L; Cassaing S; Bonneville F; Houze S; Bretagne S; Herbrecht R; Lortholary O; Naggara O; Lanternier F;
J Infect; 2022 Feb; 84(2):227-236. PubMed ID: 34838593
[TBL] [Abstract][Full Text] [Related]
64. Laboratory diagnosis of invasive aspergillosis: from diagnosis to prediction of outcome.
Barton RC
Scientifica (Cairo); 2013; 2013():459405. PubMed ID: 24278780
[TBL] [Abstract][Full Text] [Related]
65. A validated clinical approach for the management of aspergillosis in critically ill patients: ready, steady, go!
Garnacho-Montero J; Amaya-Villar R
Crit Care; 2006; 10(2):132. PubMed ID: 16584528
[TBL] [Abstract][Full Text] [Related]
66. [Microbiological diagnosis of invasive mycosis].
García J; Pemán J
Rev Iberoam Micol; 2018; 35(4):179-185. PubMed ID: 30471895
[TBL] [Abstract][Full Text] [Related]
67. Breaking the mould - novel diagnostic and therapeutic strategies for invasive pulmonary aspergillosis in the immune deficient patient.
Thornton CR
Expert Rev Clin Immunol; 2014 Jun; 10(6):771-80. PubMed ID: 24689528
[TBL] [Abstract][Full Text] [Related]
68. Immunohistochemical expression of galactomannan in the cytoplasm of phagocytic cells during invasive aspergillosis.
Piérard GE; Arrese Estrada J; Piérard-Franchimont C; Thiry A; Stynen D
Am J Clin Pathol; 1991 Sep; 96(3):373-6. PubMed ID: 1877535
[TBL] [Abstract][Full Text] [Related]
69. Aspergillus antibody detection: diagnostic strategy and technical considerations from the Société Française de Mycologie Médicale (French Society for Medical Mycology) expert committee.
Persat F; Hennequin C; Gangneux JP;
Med Mycol; 2017 Apr; 55(3):302-307. PubMed ID: 27703021
[TBL] [Abstract][Full Text] [Related]
70. Invasive Aspergillus Laryngotracheobronchitis in an Adult with Primary CNS Lymphoma.
Barry ME; Thomas WW; Song B; Mirza N
Mycopathologia; 2017 Aug; 182(7-8):733-737. PubMed ID: 28213800
[TBL] [Abstract][Full Text] [Related]
71. Immunoproteomics of Aspergillus for the development of biomarkers and immunotherapies.
Kniemeyer O; Ebel F; Krüger T; Bacher P; Scheffold A; Luo T; Strassburger M; Brakhage AA
Proteomics Clin Appl; 2016 Oct; 10(9-10):910-921. PubMed ID: 27312145
[TBL] [Abstract][Full Text] [Related]
72. Aspects of oxalosis associated with aspergillosis in pathology specimens.
Pabuççuoğlu U
Pathol Res Pract; 2005; 201(5):363-8. PubMed ID: 16047945
[TBL] [Abstract][Full Text] [Related]
73. The current status of avian aspergillosis diagnoses: Veterinary practice to novel research avenues.
Savelieff MG; Pappalardo L; Azmanis P
Vet Clin Pathol; 2018 Sep; 47(3):342-362. PubMed ID: 30117564
[TBL] [Abstract][Full Text] [Related]
74. Laboratory detection and identification of Aspergillus species by microscopic observation and culture: the traditional approach.
McClenny N
Med Mycol; 2005 May; 43 Suppl 1():S125-8. PubMed ID: 16110804
[TBL] [Abstract][Full Text] [Related]
75. A Case of Primary Invasive Aspergillus Colitis Masquerading as Clostridium difficile Infection.
Reynolds IS; O'Connell K; Fitzpatrick F; Masania R; Richardson M; McNamara DA
Surg Infect (Larchmt); 2016 Apr; 17(2):262-3. PubMed ID: 26780696
[No Abstract] [Full Text] [Related]
76. Impact of diagnostic markers on early antifungal therapy.
Jones BL; McLintock LA
Curr Opin Infect Dis; 2003 Dec; 16(6):521-6. PubMed ID: 14624100
[TBL] [Abstract][Full Text] [Related]
77. British Society for Medical Mycology best practice recommendations for the diagnosis of serious fungal diseases.
Schelenz S; Barnes RA; Barton RC; Cleverley JR; Lucas SB; Kibbler CC; Denning DW;
Lancet Infect Dis; 2015 Apr; 15(4):461-74. PubMed ID: 25771341
[TBL] [Abstract][Full Text] [Related]
78. Laboratory diagnostics of invasive fungal infections: an overview with emphasis on molecular approach.
Bašková L; Buchta V
Folia Microbiol (Praha); 2012 Sep; 57(5):421-30. PubMed ID: 22566119
[TBL] [Abstract][Full Text] [Related]
79. State of the art diagnostic of mold diseases: a practical guide for clinicians.
Beirão F; Araujo R
Eur J Clin Microbiol Infect Dis; 2013 Jan; 32(1):3-9. PubMed ID: 22903167
[TBL] [Abstract][Full Text] [Related]
80. Immunodiagnosis of aspergillosis.
Kurup VP; Kumar A
Clin Microbiol Rev; 1991 Oct; 4(4):439-56. PubMed ID: 1747861
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
